MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AXSM — Axsome Therapeutics, Inc
NasdaqAxsome Therapeutics, Inc
$179.25
-2.82(-1.55%)
- O
- 182.55
- H
- 182.55
- L
- 175.46
- V
- 981.12K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About AXSM
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateNov 19, 2015
Employees925
Stock ExchangeNasdaq
Ticker SymbolAXSM
Websitehttps://www.axsome.com
Key Financial Statistics
| Market Cap | $10.22B |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $117.30 - $260.19 |
| 52-Week Avg Volume | 699.8K |
| VWAP | $178.98 |
| Transactions | 20,685 |
| Total Recorded Bars | 2,732 days |